Benzinga | Feb 12, 2021 07:15AM EST

Ladenburg Thalmann Initiates Coverage On Artelo Biosciences with Buy Rating, Announces Price Target of $7

Ladenburg Thalmann analyst Michael Higgins initiates coverage on Artelo Biosciences (NASDAQ:ARTL) with a Buy rating and announces Price Target of $7.